William Traverse to Behcet Syndrome
This is a "connection" page, showing publications William Traverse has written about Behcet Syndrome.
Connection Strength
0.652
-
Thomas S, Bae C, Joy-Ann T, Traverse W. Behcet's-like syndrome following pembrolizumab: An immune-related adverse event associated with programmed death receptor-1 inhibitor therapy. J Oncol Pharm Pract. 2020 Jun; 26(4):995-999.
Score: 0.652